Gary L. Davis, MD

Sherif  Saadeh, MD
Division of Hepatology, Baylor University Medical Center, Dallas, Tex

Gary L. Davis, MD
Division of Hepatology, Baylor University Medical Center, Dallas, Tex

Correspondence: Gary L. Davis, MD, 4 Roberts, BUMC, 3500 Gaston Avenue, Dallas, TX 75246; e-mail: GaryDav@BaylorHealth.edu

Dr. Saadeh reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Davis reported that he has received grant or research support from the Roche, SciClone, Otsuka, Gilead, and InterMune corporations.

Sherif  Saadeh, MD
Division of Hepatology, Baylor University Medical Center, Dallas, Tex

Gary L. Davis, MD
Division of Hepatology, Baylor University Medical Center, Dallas, Tex

Correspondence: Gary L. Davis, MD, 4 Roberts, BUMC, 3500 Gaston Avenue, Dallas, TX 75246; e-mail: GaryDav@BaylorHealth.edu

Dr. Saadeh reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Davis reported that he has received grant or research support from the Roche, SciClone, Otsuka, Gilead, and InterMune corporations.

Sherif  Saadeh, MD
Division of Hepatology, Baylor University Medical Center, Dallas, Tex

Gary L. Davis, MD
Division of Hepatology, Baylor University Medical Center, Dallas, Tex

Correspondence: Gary L. Davis, MD, 4 Roberts, BUMC, 3500 Gaston Avenue, Dallas, TX 75246; e-mail: GaryDav@BaylorHealth.edu

Dr. Saadeh reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Davis reported that he has received grant or research support from the Roche, SciClone, Otsuka, Gilead, and InterMune corporations.